Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5F. Hoffmann-La Roche

02 1Genentech

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Ocrelizumabum

Brand Name : Ocrevus

Dosage Form : Inf Conc

Dosage Strength : 300mg/10ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

OCRELIZUMAB

Brand Name : OCREVUS

Dosage Form : SOLUTION

Dosage Strength : 30MG/ML

Packaging : 15ML VIAL

Approval Date :

Application Number : 2467224

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Ocrelizumab

Brand Name : Ocrevus

Dosage Form : INF

Dosage Strength : 300mg

Packaging : 10X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

04

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

ocrelizumab

Brand Name : Ocrevus

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

ocrelizumab

Brand Name : Ocrevus

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

OCRELIZUMAB

Brand Name : OCREVUS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 30MG/1ML

Packaging :

Approval Date :

Application Number : 761053

Regulatory Info :

Registration Country : USA

blank